A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate–Severe Asthma

A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate–Severe Asthma

Introduction: The relationship between immediate symptom control, reliever medication use and exacerbation risk on treatment response and factors that modify it have not been assessed in an integrated manner. Here we apply simulation scenarios to evaluate the effect of individual baseline characteri...

Full description

Bibliographic Details
Main Authors:	Garcia, G, van Dijkman, SC, Pavord, I, Singh, D, Oosterholt, S, Fulmali, S, Majumdar, A, Della Pasqua, O
Format:	Journal article
Language:	English
Published:	Springer 2024

Similar Items

Exacerbations of severe asthma in patients treated with mepolizumab
by: Shrimanker, R, et al.
Published: (2018)

Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design
by: Tim Harrison, et al.
Published: (2020-06-01)

EAACI position statement on asthma exacerbations and severe asthma.
by: Custovic, A, et al.
Published: (2013)

Dupilumab reduces severe exacerbation rate and improves lung function in adolescent patients with uncontrolled, moderate-to-severe asthma: from the Liberty Asthma Quest study
by: Maspero, J, et al.
Published: (2018)

Impact of Baseline Lung Function on Future Exacerbations in Patients with Moderate-to-Severe Asthma
by: Khan AH, et al.
Published: (2022-11-01)

Predictive factors for moderate or severe exacerbations in asthma patients receiving outpatient care
by: Francisco Javier Álvarez Gutiérrez, et al.
Published: (2017-05-01)

Treating asthma exacerbations in athletes: TUE or not TUE?
by: Hull, J, et al.
Published: (2017)

Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study
by: Guilbert TW, et al.
Published: (2024-03-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
by: Shrimanker, R, et al.
Published: (2017)

Comparison of several combinations maintenance and reliever therapy for asthma patients
by: Pablo Andrés Miranda-Machado
Published: (2018-06-01)

Single inhaler maintenance and reliever therapy (SMART) in general practice asthma management: where are we?
by: Thomas, M, et al.
Published: (2012)

The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy
by: Buhl Roland, et al.
Published: (2012-07-01)

Dupilumab reduces risk of severe exacerbations and improves FEV1 in patients on both high- and medium dose ICS with uncontrolled, moderate-to-severe asthma from the phase 3 LIBERTY ASTHMA QUEST Study
by: Pavord, I, et al.
Published: (2018)

Peak expiratory flow sequence in acute exacerbations of asthma.
by: Birring, S, et al.
Published: (2001)

Monitoring asthma in childhood: symptoms, exacerbations and quality of life
by: Paul L.P. Brand, et al.
Published: (2015-06-01)

Critical Care Management of Severe Asthma Exacerbations
by: Shameek Gayen, et al.
Published: (2024-02-01)

Ventilating my thoughts on severe asthma exacerbations
by: M L Wong
Published: (2023-08-01)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
by: Haldar, P, et al.
Published: (2009)

Measuring respiratory symptoms in moderate/severe asthma: evaluation of a respiratory symptom tool, the E-RS®: COPD in asthma populations
by: Maggie Tabberer, et al.
Published: (2021-10-01)

Evaluating minimal important differences and responder definitions for the asthma symptom diary in patients with moderate to severe asthma
by: Gary Globe, et al.
Published: (2019-04-01)

Effects of Arthro-7® in relieving symptoms of osteoarthritis with mild to moderate arthralgia
by: Xie Q, et al.
Published: (2013-03-01)

Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma
by: Richard Beasley, et al.
Published: (2019-12-01)

Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database
by: Lee H, et al.
Published: (2016-04-01)

Patient and physician evaluation of the severity of acute asthma exacerbations
by: J.A. Atta, et al.
Published: (2004-09-01)

Patient and physician evaluation of the severity of acute asthma exacerbations
by: Atta J.A., et al.
Published: (2004-01-01)

Effective control of a severe exacerbation of bronchial asthma
by: V I Makolkin, et al.
Published: (2004-08-01)

Age-Specific Characteristics of Inpatients with Severe Asthma Exacerbation
by: Kiyoshi Sekiya, et al.
Published: (2013-01-01)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
by: Price, D, et al.
Published: (2019)

Effects of Arthro-7® in relieving symptoms of osteoarthritis with mild to moderate arthralgia [Corrigendum]
by: Xie Q, et al.
Published: (2013-05-01)

The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data
by: Andrew Briggs, et al.
Published: (2021-01-01)

Dupilumab efficacy and safety in moderate-to-severe uncontrolled Asthma
by: Castro, M, et al.
Published: (2018)

Achieving Symptom Control in Patients with Moderate Asthma
by: Nargues A. Weir, et al.
Published: (2011-12-01)

Achieving Symptom Control in Patients with Moderate Asthma
by: Nargues A. Weir, et al.
Published: (2012-01-01)

Dexamethasone versus Prednisolone in Relapse of Symptoms in Children with Acute Exacerbations of Asthma
by: Hijab Shaheen , Shagufta Sohail , Noshina Riaz
Published: (2021-12-01)

Mepolizumab, quality of life, and severe eosinophilic asthma.
by: Pavord, I
Published: (2017)

Patient Preferences for Attributes of Biologic Treatments in Moderate to Severe Asthma: A Discrete Choice Experiment Study
by: Yang M, et al.
Published: (2022-09-01)

Frequent exacerbators in severe asthma: Focus on clinical and transcriptional factors
by: Neil C. Thomson
Published: (2022-05-01)

Sensitization to Aspergillus species is associated with frequent exacerbations in severe asthma
by: Goh, Ken Junyang, et al.
Published: (2017)

Association of molds and metrological parameters to frequency of severe asthma exacerbation
by: Mona Al-Ahmad, et al.
Published: (2019-04-01)

Sensitization to Aspergillus species is associated with frequent exacerbations in severe asthma
by: Goh KJ, et al.
Published: (2017-04-01)